Search

everythinglearnresearchcommunity

for

Search:↓

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Adding a second method to PROTACs could improve cancer treatment.

PRP improves short-term pain and function in shoulder injuries, but long-term benefits are unclear.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

DPCP can help regrow hair in some people with severe alopecia.

PRP reduces complications in hair transplants.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

TriCell CD34+ cell-containing PRP therapy improves hair thickness and density in alopecia patients without side effects.